The global female infertility diagnosis and treatment market is anticipated to grow at a favorable CAGR of 5.6% during the forecast period (2022-2028). The major factor that enhances the market growth is, the rising prevalence of sexually transmitted infections (SITs), the surge in vitro fertilization(IVF) due to its success rate, and the recent approval by the government allowing lesbian couples as well as single women to access the procedure. For instance, in June 2021, France’s lower house of parliament passed a law, that allows single women and lesbians to medically assisted reproduction for the first time. The new law provides access to fertility treatment such as artificial insemination and in vitro fertilization (IVF), and fertility treatment is free, for lesbian couples and single women.
A full report of Female Infertility Diagnosis and Treatment Market is available at: https://www.omrglobal.com/industry-reports/female-infertility-market-size
The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. for instance, in March 2022, ColumbiaUniversity Fertility center opened new clinics in White Plains, New York. The center provides advanced treatment options for fertility diagnosis, and the site offers a full suite of fertility services, including fertility screening and diagnosis, semen analysis, intrauterine insemination, oncofertility services, and daily monitoring for IUI and IVF cycles. Similarly, in December 2021, the Duke fertility center opened a new clinic in Morrisville that provides a range of features designed to enhance the patient’s experience and clinical outcomes. The services that are provided by clinics include electronic witnessing of sperm, eggs, and embryos, an air filtration unit that eliminates harmful toxins in the air, and a cutting edge system to leverage environmental data for early detection of issues and adverse trends. Duke Fertility Center will be the first center in the area to implement a radio frequency identification technology to track sperm, eggs, and embryos through each step of the laboratory process.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/female-infertility-market-size
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2021-2028
- Segment Covered- by diagnosis, by treatment, by end-user
- Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
- Competitive Landscape- are Bayer AG, Church & Dwight Co. Inc., Genea Ltd., Pfizer Inc., Vitrolife Sweden AB , Esco Group, Fairhaven Health, Ferring B.V., and others
Key questions addressed by the report
- What is the market growth rate?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Female Infertility Diagnosis and Treatment Market– Segmentation
By Diagnosis
- Ovulation Testing
- Hysterosalpingography (HSG)
- Hysteroscopy
- Imaging Testing
- Ovarian Reserve Testing
- Hormonal Level Testing
- Genetic Testing
- Others (Laparoscopy)
By Treatment
- Drugs
- Surgery
- Intrauterine Insemination (IUI)
- Assisted Reproductive Technology (ART)
By End-User
- Hospitals and Clinics
- Homecare
- Pathology and Diagnostic Centers
